The U.S. Department of Health and Human Services released its AI Strategy, the next phase of the Department’s transformative initiative to make artificial intelligence available to the federal workforce, integrating it across internal operations, research, and public health.
The Health Resources and Services Administration released new data showing HRSA-funded health centers served over 32.4 million patients in 2024 — the most patients ever served in the Health Center Program’s 60-year history.
On July 31, 2025, the Centers for Medicare & Medicaid Services issued a final rule for updates to Medicare payment policies and rates for skilled nursing facilities under the Skilled Nursing Facility Prospective Payment System for fiscal year 2026.
The CMS Making Health Tech Great Again initiative is announced. “Let’s stop waiting and let’s definitely stop faxing. Let’s start building. The right data at the right time can mean the difference between loss and hope. The time is now. Are you in?”
CMS 2026 Physician Fee Schedule Proposed Rule. The 60-day comment period for the CY 2026 PFS proposed rule (CMS-1832 P) ends on September 12, 2025.
This program is designed to support communities severely affected by homelessness and to gain insights on effective ways to identify patients, complete treatment, cure infections, and reduce reinfection by Hepatitis C (a liver disease caused by the Hepatitis C virus).
This initiative represents a decisive shift toward transparency, effectiveness, and comprehensive preparedness, funding the NIH’s in-house development of universal influenza and coronavirus vaccines, including candidates BPL-1357 and BPL-24910.
The U.S. Department of Health and Human Services and U.S. Food and Drug Administration announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant milestone in the administration’s broader initiative to Make America Healthy Again.
The Centers for Medicare & Medicaid Services announced that agreements have been signed with manufacturers of the 15 drugs covered under Medicare Part D selected for the second cycle of the Medicare Drug Price Negotiation Program.
HHS announces 15 additional drugs selected for Medicare Drug Price Negotiations in continued effort to lower prescription drug costs for seniors. Building on the success of the first round of negotiations, the aim is to lower prices for some more of the costliest prescription drugs.
HHS announced it would award $306 million dollars to continue its H5N1 Avian Flu response. While CDC’s assessment of the risk of avian influenza to the general public remains low, USDA and HHS continue to closely collaborate with Federal, State, local, industry and other stakeholders to protect human health, animal health, and food safety.
The Substance Abuse and Mental Health Services Administration, an agency within the U.S. Department of Health and Human Services, recently awarded $10 million for the Community-Based Maternal Behavioral Health Services Program, a new grant program supporting the behavioral health of pregnant and postpartum women.
©2025 Answers Media Company, LLC